PT  - JOURNAL ARTICLE
AU  - Zehender, Gianguglielmo
AU  - Lai, Alessia
AU  - Bergna, Annalisa
AU  - Meroni, Luca
AU  - Riva, Agostino
AU  - Balotta, Claudia
AU  - Tarkowski, Maciej
AU  - Gabrieli, Arianna
AU  - Bernacchia, Dario
AU  - Rusconi, Stefano
AU  - Rizzardini, Giuliano
AU  - Antinori, Spinello
AU  - Galli, Massimo
TI  - GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY
AID  - 10.1101/2020.03.15.20032870
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.15.20032870
4099  - http://medrxiv.org/content/early/2020/03/20/2020.03.15.20032870.short
4100  - http://medrxiv.org/content/early/2020/03/20/2020.03.15.20032870.full
AB  - This report describes the isolation, the molecular characterization and the phylogenetic analysis of the first three complete genomes of SARS-CoV-2 isolated from three patients involved in the first outbreak of COVID-19 in Lombardy, Italy. Early molecular epidemiological tracing suggests that SARS-CoV-2 was present in Italy weeks before the first reported cases of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA paper have been submitted to Journal of Medical Virology.